Skip to main content
Log in

Hypoglycemia, an Atypical Early Sign of Hepatocellular Carcinoma

  • Brief Communication
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background

Hypoglycemia is extremely uncommon as the first presentation of hepatocellular carcinoma, and it occurs predominantly as a paraneoplastic manifestation.

Methods

We report a case of a 38-year-old-man positive for hepatitis B surface antigen with high-serum viremia who presented with symptoms of acute severe hypoglycemia.

Results

Laboratory tests confirmed hypoglycemia (serum glucose 1.54 mmol/L) with undetectable serum-C peptide (<0.5 µIU/mL) and slightly increased serum insulin concentration (35 µIU/mL). Alpha-fetoprotein serum level was 75,625 ng/mL. Abdominal ultrasonography and computed tomography revealed a big vascularized mass of 13 cm in diameter occupying most of the right lobe of the liver and an 18F-fluoro-2-deoxy-D-glucose positron-emission tomography revealed a predominant uptake of glucose by the tumor mass.

Conclusions

These findings indicate that hepatocellular carcinoma-associated hypoglycemia may be due exclusively to increased glucose utilization by the tumor mass.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. World Health Organization. (2008). Mortality database. Available from: http://www.who.int/whosis/en

  2. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci. 2002;963:13–20.

    Article  PubMed  Google Scholar 

  3. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005;25:143–54.

    Article  PubMed  Google Scholar 

  4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  5. Ross JS, Kurian S. Clear cell hepatocellular carcinoma: sudden death from severe hypoglycemia. Am J Gastroenterol. 1985;80:188–94.

    CAS  PubMed  Google Scholar 

  6. Ndububa DA, Ojo OS, Adetiloye VA, Rotimi O, Durosinmi MA, Uchegbu LO. The incidence and characteristics of some paraneoplastic syndromes of hepatocellular carcinoma in Nigerian patients. Eur J Gastroenterol Hepatol. 1999;11:1401–4.

    Article  CAS  PubMed  Google Scholar 

  7. Chu CW, Hwang SJ, Luo JC, Tsay SH, Li CP, Chang FY, et al. Manifestation of hypercholesterolaemia, hypoglycemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases. J Gastroenterol Hepatol. 1999;14:807–10.

    Article  CAS  PubMed  Google Scholar 

  8. Luo JC, Hwang SJ, Wu JC, Lai CR, Li CP, Chang FY, et al. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology. 2002;49:1315–9.

    PubMed  Google Scholar 

  9. Saigal S, Nandeesh HP, Malhotra V, Sarin SK. A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol. 1998;93:1380–1.

    Article  CAS  PubMed  Google Scholar 

  10. Nikeghbalian S, Bananzadeh A, Yarmoammadi H. Hypoglycemia, the first presenting sign of hepatocellular carcinoma. Saudi Med J. 2006;27:387–8.

    PubMed  Google Scholar 

  11. McFadzean AJ, Yeung RTT. Hypoglycemia in primary carcinoma of the liver. Arch Intern Med. 1956;98:720–31.

    CAS  Google Scholar 

  12. McFadzean AJ, Yeung RTT. Further observations on hypoglycemia in hepatocellular carcinoma. Am J Med. 1969;47:220–35.

    Article  CAS  PubMed  Google Scholar 

  13. Yeung RTT. Hypoglycemia in hepatocellular carcinoma: a review. HKMJ. 1997;3:297–301.

    PubMed  Google Scholar 

  14. Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor II. J Clin Invest. 1990;85:1672–9.

    Article  CAS  PubMed  Google Scholar 

  15. Eastman RC, Carson RE, Orloff DG, Cochran CS, Perdue JF, Rechler MM, et al. Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. J Clin Invest. 1992;89:1958–63.

    Article  CAS  PubMed  Google Scholar 

  16. Yonei Y, Tanaka M, Ozawa Y, Miyazaki K, Tsukada N, Inada S, et al. Primary hepatocellular carcinoma with severe hypoglycemia; involvement of insulin-like growth factors. Liver. 1992;12:90–3.

    CAS  PubMed  Google Scholar 

  17. Yamaguchi M, Kamimura S, Takada J, Iwata K, Iida T, Kobayashi K, et al. Case report: insulin-like growth factors II expression in hepatocellular carcinoma with alcoholic liver fibrosis accompanied by hypoglycemia. J Gastroenterol Hepatol. 1998;13:47–51.

    Article  CAS  PubMed  Google Scholar 

  18. Ishida S, Noda M, Kuzuya N, Kubo F, Yamada S, Yamanaka T, et al. Big insulin-like growth factor II- producing hepatocellular carcinoma associated with hypoglicemia. Intern Med. 1995;34:1201–6.

    Article  CAS  PubMed  Google Scholar 

  19. Kahn CR. The riddle of tumor hypoglycemia revisited. Clin Endocrinol Metabol. 1980;95:505–17.

    Google Scholar 

  20. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med. 1988;319:1434–40.

    Article  CAS  PubMed  Google Scholar 

  21. Thorgeirsson SS, Grishman JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–46.

    Article  CAS  PubMed  Google Scholar 

  22. Aihara T, Noguchi S, Miyoshi Y, Nakano H, Sasaki Y, Nakamura Y, et al. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver. Hepatology. 1998;28:86–9.

    Article  CAS  PubMed  Google Scholar 

  23. August JT, Hiatt HH. Severe hypoglycemia secondary to a nonpancreatic fibrosarcoma with insulin activity. N Engl J Med. 1958;258:17–20.

    Article  CAS  PubMed  Google Scholar 

  24. Perkoff GT, Simons EL. Hypoglycemia in a patient with a fibrous tumor. Arch Intern Med. 1963;112:589–93.

    CAS  PubMed  Google Scholar 

  25. Chowdhury F, Bleicher SJ. Studies of tumor hypglycemia. Metab Clin Exp. 1973;22:663–74.

    CAS  PubMed  Google Scholar 

  26. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomised rats. J Clin Invest. 1986;77:1768–75.

    Article  CAS  PubMed  Google Scholar 

  27. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology. 1995;21:680–8.

    CAS  PubMed  Google Scholar 

  28. Duffy MJ, Crown J. A personalized approach to cancer treatment: how biomarkers can help. Clin Chem. 2008;54:1170.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Romanelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sorlini, M., Benini, F., Cravarezza, P. et al. Hypoglycemia, an Atypical Early Sign of Hepatocellular Carcinoma. J Gastrointest Canc 41, 209–211 (2010). https://doi.org/10.1007/s12029-010-9137-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-010-9137-0

Keywords

Navigation